全文获取类型
收费全文 | 264881篇 |
免费 | 22595篇 |
国内免费 | 9809篇 |
专业分类
耳鼻咽喉 | 1265篇 |
儿科学 | 9185篇 |
妇产科学 | 1748篇 |
基础医学 | 22838篇 |
口腔科学 | 3692篇 |
临床医学 | 26961篇 |
内科学 | 67720篇 |
皮肤病学 | 2898篇 |
神经病学 | 26284篇 |
特种医学 | 8376篇 |
外国民族医学 | 19篇 |
外科学 | 23116篇 |
综合类 | 39285篇 |
现状与发展 | 47篇 |
一般理论 | 9篇 |
预防医学 | 19825篇 |
眼科学 | 2412篇 |
药学 | 20644篇 |
207篇 | |
中国医学 | 13894篇 |
肿瘤学 | 6860篇 |
出版年
2024年 | 279篇 |
2023年 | 5080篇 |
2022年 | 6832篇 |
2021年 | 12656篇 |
2020年 | 12807篇 |
2019年 | 9970篇 |
2018年 | 9822篇 |
2017年 | 10132篇 |
2016年 | 10809篇 |
2015年 | 10279篇 |
2014年 | 18766篇 |
2013年 | 20492篇 |
2012年 | 15664篇 |
2011年 | 17069篇 |
2010年 | 13411篇 |
2009年 | 12934篇 |
2008年 | 12934篇 |
2007年 | 12671篇 |
2006年 | 11616篇 |
2005年 | 9601篇 |
2004年 | 8063篇 |
2003年 | 6958篇 |
2002年 | 5953篇 |
2001年 | 5204篇 |
2000年 | 4293篇 |
1999年 | 3586篇 |
1998年 | 3225篇 |
1997年 | 2762篇 |
1996年 | 2479篇 |
1995年 | 2504篇 |
1994年 | 2333篇 |
1993年 | 1970篇 |
1992年 | 1863篇 |
1991年 | 1612篇 |
1990年 | 1339篇 |
1989年 | 1146篇 |
1988年 | 1047篇 |
1987年 | 920篇 |
1986年 | 816篇 |
1985年 | 957篇 |
1984年 | 819篇 |
1983年 | 512篇 |
1982年 | 600篇 |
1981年 | 515篇 |
1980年 | 411篇 |
1979年 | 350篇 |
1978年 | 290篇 |
1977年 | 246篇 |
1976年 | 233篇 |
1975年 | 102篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
61.
62.
63.
64.
65.
66.
《Archivos de bronconeumología》2022,58(1):11-21
BackgroundWe aimed to describe the effectiveness and safety of inhaled antibiotics in chronic obstructive pulmonary disease (COPD) patients, as well as the patient profile in which they are usually prescribed and the patient groups that can most benefit from this treatment.MethodsMulticentre retrospective observational cohort study in COPD patients who had received ≥1 dose of inhaled antibiotics in the last 5 years. Clinical data from the two years prior to and subsequent to the start of the treatment were compared. Primary outcome: COPD exacerbations. Secondary outcomes: side effects, symptomatology (sputum purulence, dyspnoea), microbiological profile and pathogen eradication.ResultsOf 693 COPD patients analyzed (aged 74.1; 86.3% men; mean FEV1 = 43.7%), 71.7% had bronchiectasis and 46.6% presented chronic bronchial infection (CBI) by Pseudomonas aeruginosa (PA). After 1 year of treatment with inhaled antibiotics, there was a significant decrease in the number of exacerbations (?33.3%; P < .001), hospital admissions (?33.3%; P < .001) and hospitalization days (?26.2%; P = .003). We found no difference in effectiveness between patients with or without associated bronchiectasis. Positive patient outcomes were more pronounced in PA-eradicated patients. We found a significant reduction in daily expectoration (?33.1%; P = .024), mucopurulent/purulent sputum (?53.9%; P < .001), isolation of any potentially pathogenic microorganisms (PPM) (?16.7%; P < .001), CBI by any PPM (?37.4%; P < .001) and CBI by PA (?49.8%; P < .001). CBI by any PPM and ≥three previous exacerbations were associated with a better treatment response. 25.4% of patients presented non-severe side-effects, the most frequent of these being bronchospasm (10.5%), dyspnoea (8.8%) and cough (1.7%).ConclusionsIn COPD patients with multiple exacerbations and/or CBI by any PPM (especially PA), inhaled antibiotics appear to be an effective and safe treatment, regardless of the presence of bronchiectasis. 相似文献
67.
Glaucoma is a leading cause of irreversible blindness. The use of topical eye drops to reduce intraocular pressure remains the mainstay treatment. These eye drops frequently contain preservatives designed to ensure sterility of the compound. A growing number of clinical and experimental studies report the detrimental effects of not only these preservatives but also the active pharmaceutical compounds on the ocular surface, with resultant tear film instability and dry eye disease. Herein, we critically appraise the published literature exploring the effects of preservatives and pharmaceutical compounds on the ocular surface. 相似文献
68.
A 25-year-old, emaciated man without medical treatment was found to have died suddenly at home by his mother. At autopsy, there were no injuries to his body, but significant circulatory insufficiency was observed. Electron microscopy revealed abnormal mitochondria in cells of the cardiac conduction system. The conduction system was filled with mitochondrial size abnormalities and mitochondrial cristae abnormalities. No notable abnormal findings were observed in other organs. Genetic examination of the blood revealed the mitochondrial pathogenetic variant m.3243A>G. Epileptic seizures, diabetic ketoacidosis, and hyperosmolar hyperglycemic state were unlikely to be the cause of sudden death. The cause of death was diagnosed as arrhythmia possibly induced by the failure of the cardiac conduction system due to mitochondrial disease. This is a rare case of sudden death caused by an accumulation of abnormal mitochondria in the cardiac conduction system. 相似文献
69.
目的探讨乙肝相关性肝癌临床病理学特征与溶血磷脂酸(LPA)和高敏C反应蛋白(hs-CRP)表达的相关性。方法选取2019年1月至2020年1月间河南省驻马店市中心医院收治的198例乙肝相关性肝癌患者作为乙肝组,198例酒精相关性肝癌患者作为酒精组。两组患者都进行血清hs-CRP和LPA表达检测,调查患者的病理学特征并进行相关性分析。结果乙肝组患者血清hs-CRP和LPA含量均高于酒精组,差异均有统计学意义(均P <0.05)。两组患者血清ALP、AFP、ALT、AST和GGT含量比较,差异均无统计学意义(P> 0.05)。乙肝组不同临床分期和组织学分化患者的血清hs-CRP和LPA含量比较,差异均有统计学意义(均P <0.05)。乙肝组患者的临床分期和组织学分化与血清hs-CRP和LPA表达均存在相关性,差异均有统计学意义(均P <0.05)。患者的临床分期和组织学分化均为影响hs-CRP和LPA表达的重要因素,差异均有统计学意义(均P <0.05)。结论相对于酒精相关性肝癌,乙肝相关性肝癌的血清hs-CRP和LPA呈现高表达,与患者的临床病理学特征存在相关性。 相似文献
70.
目的:探讨初诊急性白血病患者化疗期间应用伏立康唑进行预防侵袭性真菌病(IFD)的临床疗效及安全性。方法:回顾性分析2016年02月至2018年03月期间我院血液科收治的初诊急性白血病行化疗的患者166例,按照是否使用抗真菌药进行预防性治疗分为观察组(应用伏立康唑进行预防治疗,n=103)和对照组(未应用抗真菌药物,n=63),比较两组患者IFD发生率差异,并分析抗真菌药物应用的不良反应。结果:观察组IFD发生率为10.7%,对照组为33.3%,两组患者的IFD发生率有明显差异(P<0.05);所有应用伏立康唑进行预防治疗的患者均未出现严重的不良反应。结论:伏立康唑可以有效减低急性白血病患者化疗期间IFD发生率,并且有着较好的安全性,值得在临床推广应用。 相似文献